BIT Capital’s Repare Therapeutics RPTX Stock Holding History

BIT Capital’s Portfolio RPTX Stock Details RPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-9,766	Closed	-$118K	–	134
2023 Q3	$118K	Buy	+9,766	New	+$101K	0.01%	96

Other funds holding RPTX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BIT Capital's RPTX Position: Q4 2023 in Review

BIT Capital sold out of Repare Therapeutics (RPTX) in Q4 2023, closing a stake of 9,766 shares — an estimated $118K sold.

BIT Capital first reported a position in RPTX in Q3 2023 and held it in 1 quarter. The position peaked at $118K in Q3 2023. 69 funds tracked by Wall St. Rank hold RPTX as of Q4 2023.

BIT Capital reported no remaining Repare Therapeutics position as of Q4 2023 after selling out during the quarter.
BIT Capital sold 9,766 Repare Therapeutics shares in Q4 2023, an estimated $118K.
BIT Capital first reported a position in Repare Therapeutics in Q3 2023 and held it in 1 quarter.
BIT Capital's Repare Therapeutics position peaked at $118K in Q3 2023.
69 funds tracked by Wall St. Rank held Repare Therapeutics as of Q4 2023.

Based on BIT Capital's 13F filing for Q4 2023, filed 12 Feb 2025.